Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (1-10 of 320) with videos related to

Pageof 32
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 21, 2021
Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative reviewAlessandro Armuzzi, Giuseppina Liguori
Nature Reviews. Gastroenterology & Hepatology|March 23, 2011
IBD: Adalimumab for ulcerative colitis— is the glass half empty or half full?Alessandro Armuzzi, Daniela Pugliese
Clinical and Experimental Gastroenterology|September 10, 2011
Update on the management of inflammatory bowel disease: specific role of adalimumabLuisa Guidi, Daniela Pugliese, Alessandro Armuzzi
Frontiers in Pharmacology|July 11, 2017
Frontiers in Drug Research and Development for Inflammatory Bowel DiseaseDiego Currò, Daniela Pugliese, Alessandro Armuzzi
Inflammatory Bowel Diseases|June 10, 2023
Association of Depression With Incident Inflammatory Bowel Diseases: A Systematic Review and Meta-AnalysisDaniele Piovani, Alessandro Armuzzi, Stefanos Bonovas
Journal of Crohn'S & Colitis|October 5, 2018
Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication StrategiesAlessandro Armuzzi, Luisa Avedano, Kay Greveson, et al.
Nutrients|September 9, 2020
Diet and Nutrients in Gastrointestinal Chronic DiseasesAntonio Corsello, Daniela Pugliese, Antonio Gasbarrini, et al.
World Journal of Gastroenterology|May 8, 2014
Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?Gianluca Rizzo, Daniela Pugliese, Alessandro Armuzzi, et al.
United European Gastroenterology Journal|May 8, 2024
Therapeutic sequencing in inflammatory bowel disease: Determining the optimal position of vedolizumab for long-term Crohn's disease control using real-world evidenceEdouard Louis, Michal Litkiewicz, Christian Agboton, et al.
Drug Design, Development and Therapy|May 1, 2013
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumabAlessandro Armuzzi, Daniela Pugliese, Olga Maria Nardone, et al.
Pageof 32

Showing results (1-10 of 320) with videos related to

Sort By:
Pageof 32
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 21, 2021
Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative reviewAlessandro Armuzzi, Giuseppina Liguori
Nature Reviews. Gastroenterology & Hepatology|March 23, 2011
IBD: Adalimumab for ulcerative colitis— is the glass half empty or half full?Alessandro Armuzzi, Daniela Pugliese
Clinical and Experimental Gastroenterology|September 10, 2011
Update on the management of inflammatory bowel disease: specific role of adalimumabLuisa Guidi, Daniela Pugliese, Alessandro Armuzzi
Frontiers in Pharmacology|July 11, 2017
Frontiers in Drug Research and Development for Inflammatory Bowel DiseaseDiego Currò, Daniela Pugliese, Alessandro Armuzzi
Inflammatory Bowel Diseases|June 10, 2023
Association of Depression With Incident Inflammatory Bowel Diseases: A Systematic Review and Meta-AnalysisDaniele Piovani, Alessandro Armuzzi, Stefanos Bonovas
Journal of Crohn'S & Colitis|October 5, 2018
Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication StrategiesAlessandro Armuzzi, Luisa Avedano, Kay Greveson, et al.
Nutrients|September 9, 2020
Diet and Nutrients in Gastrointestinal Chronic DiseasesAntonio Corsello, Daniela Pugliese, Antonio Gasbarrini, et al.
World Journal of Gastroenterology|May 8, 2014
Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?Gianluca Rizzo, Daniela Pugliese, Alessandro Armuzzi, et al.
United European Gastroenterology Journal|May 8, 2024
Therapeutic sequencing in inflammatory bowel disease: Determining the optimal position of vedolizumab for long-term Crohn's disease control using real-world evidenceEdouard Louis, Michal Litkiewicz, Christian Agboton, et al.
Drug Design, Development and Therapy|May 1, 2013
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumabAlessandro Armuzzi, Daniela Pugliese, Olga Maria Nardone, et al.
Pageof 32